About Purinomia Biotech
Purinomia Biotech is a private company based in Woburn, Massachusetts. It has reported $10,308,269 raised in eight offerings on Form D since November 2017. Its chief executive is Yan Wu Shang.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 24, 2024 | Jun 7, 2024 | $1,000,000of $2.0M target | 1 | $1.0M | DebtRule 506(b) | Form D ↗ |
| Oct 25, 2023 | Nov 7, 2023 | $1,000,000fully sold | 1 | $1.0M | Debt, OptionsRule 506(b) | Form D ↗ |
| Apr 7, 2023 | Apr 21, 2023 | $500,000fully sold | 1 | $500K | Debt, OptionsRule 506(b) | Form D ↗ |
| Oct 31, 2022 | Jan 6, 2023 | $1,500,000fully sold | 1 | $1.5M | Debt, OptionsRule 506(b) | Form D ↗ |
| Dec 21, 2021 | Jan 5, 2022 | $1,300,000of $3.0M target | 2 | $650K | Debt, OptionsRule 506(b) | Form D ↗ |
| Feb 5, 2021 | Feb 22, 2021 | $1,999,998fully sold | 1 | $1.9M | EquityRule 506(b) | Form D ↗ |
| May 7, 2020 | May 22, 2020 | $2,828,251of $3.8M target | 3 | $942K | EquityRule 506(b) | Form D ↗ |
| Nov 14, 2017 | Nov 29, 2017 | $180,020of $1.5M target | 1 | $180K | DebtRule 506(b) | Form D ↗ |
| Total, eight offerings | $10,308,269 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Purinomia Biotech's Form D filed Jun 7, 2024.
QL
Qianye Karen Liu
Director
YS
Yan Wu Shang
President and CEO, director
SH
Shaoyong Hu
Director
SR
Simon Robson
Director
ZW
Zhe Wang
Executive officer and director